Is cerebral amyloid angiopathy genetic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is CAA Genetic?

Most cases of cerebral amyloid angiopathy (CAA) are sporadic and age-related, but rare hereditary forms do exist with autosomal dominant inheritance patterns, typically presenting before age 50 with more severe disease progression. 1

Sporadic vs. Hereditary CAA

The vast majority of CAA cases are sporadic and represent an age-related condition affecting individuals primarily in the fifth decade of life and beyond 2. However, clinicians must recognize that hereditary forms exist and present distinctly:

When to Suspect Hereditary CAA

You should suspect genetic CAA in patients younger than 50 years, particularly when:

  • There is a history of an affected first-degree relative
  • Multiple first-degree relatives are affected 1

Genetic Mutations in Hereditary CAA

Rare causes of early-onset Aβ-CAA include autosomal dominant genetic mutations in:

  • APP (amyloid precursor protein) - mutations in the middle portion of Aβ
  • Presenilin-2 (and presenilin-1)
  • For non-Aβ CAA: transthyretin, BRI2, or cystatin-C 1

Critical distinction: Missense mutations associated with hereditary CAA are located in the middle portion of Aβ, while those associated with familial Alzheimer's disease are near the N- or C-terminals of Aβ 3. This explains why some families develop primarily vascular disease while others develop parenchymal Alzheimer's pathology.

Genetic Risk Factors in Sporadic CAA

While not "genetic" in the hereditary sense, APOE genotype significantly influences sporadic CAA risk:

  • APOE ε4 allele: Dose-dependent association with CAA development (OR 2.7,95% CI 2.3-3.1) 4
  • APOE ε2 allele: Associated with CAA-related hemorrhage risk rather than CAA development itself 4, 3

Other genetic polymorphisms showing preliminary associations include transforming growth factor β1, TOMM40, and complement component receptor 1 (CR1) genes 1, 5.

Iatrogenic CAA: A Special Consideration

A third category exists beyond sporadic and hereditary: Iatrogenic CAA is caused by seeding of the CNS with exogenous Aβ, linked to:

  • Transplanted human dura mater
  • Embolization of lyophilized dura mater
  • Human cadaveric pituitary-derived growth hormone

These cases typically manifest after a latency period of several decades 1. Therefore, careful questioning about history of neurosurgery or relevant procedures is essential in any person with possible CAA symptoms.

Clinical Implications

The key clinical takeaway: While most CAA is sporadic and age-related, always obtain a detailed family history and surgical history. Early-onset disease (before age 50) with positive family history should prompt consideration of genetic testing and genetic counseling, as hereditary forms follow autosomal dominant patterns with more aggressive courses 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.